The effect of race on composite thrombotic events in patients with COVID-19

Link to article at PubMed

Thromb Res. 2021 Mar;199:10-13. doi: 10.1016/j.thromres.2020.12.015. Epub 2020 Dec 29.


COVID-19 associated coagulopathy and mortality related to thrombotic complications have been suggested as biological mediators in racial disparities related to COVID-19. We studied the adjusted prevalence of acute ischemic stroke, pulmonary embolism, myocardial infarction, and deep venous thrombosis stratified by race in hospitalized patients in one New York City borough during the local COVID-19 surge. The multi-racial cohort included 4299 patients hospitalized with COVID-19, 9% of whom were white, 40% black, 41% Hispanic and 10% Asian or other. We found a 6.1% prevalence of composite thrombotic events. There were no significant race-specific differences in thrombotic events when adjusting for basic demographics, socioeconomic factors, medical comorbidities or biomarkers using a stepwise regression model. We therefore found no evidence that the racial disparities related to COVID-19, and specifically thrombotic complications, are caused by biological differences in race.

PMID:33385794 | PMC:PMC7833453 | DOI:10.1016/j.thromres.2020.12.015

Leave a Reply

Your email address will not be published.